BluePath Capital Management LLC Takes $339,000 Position in Abbott Laboratories (NYSE:ABT)
BluePath Capital Management LLC acquired a new stake in Abbott Laboratories (NYSE:ABT – Free Report) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 3,505 shares of the healthcare product maker’s stock, valued at approximately $339,000. Other institutional investors also recently modified their holdings of the company. […]
Andreaf Wainer Danielj Starks Cornerstone Planning Group Financial Services Bluepath Capital Management Securities Exchange Commission
Source: tickerreport.com